Concepedia

Angèle Fleury

AF

Statistics

Publications

6

Citations

238

H-Index

6

Active since

2007

Affiliations

Boehringer Ingelheim (Germany)(Current)

Roche (Switzerland)

Angèle Fleury is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

2007–2020

6

Publications

6

Challenges and opportunities with modelling and simulation in drug discovery and drug development

Thierry Lavé, Neil Parrott, Hans Peter Grimm et al. · Xenobiotica · 2007 · 115 citations

, , +17

Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors

Matthias Freiwald, Ulrike Schmid, Angèle Fleury et al. · Cancer Chemotherapy and Pharmacology · 2014 · 53 citations

, , +9

A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine

Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana et al. · Pharmaceutics · 2020 · 25 citations · Full text

, , +16

Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis

Ulrike Schmid, Karl‐Heinz Liesenfeld, Angèle Fleury et al. · Cancer Chemotherapy and Pharmacology · 2017 · 23 citations · Full text

, , +13

Population Pharmacokinetics of Volasertib Administered in Patients with Acute Myeloid Leukaemia as a Single Agent or in Combination with Cytarabine

Belén P. Solans, Angèle Fleury, Matthias Freiwald et al. · Clinical Pharmacokinetics · 2017 · 12 citations

, , +11

1–5 of 6